SCHEMBL31050058

SCHEMBL31050058

CC(C)(C)OC(=O)n1ncc2c(Cl)c(Br)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 1/20 0.39
▸ ROCK2 O75116 2/20 0.39
▸ ROCK1 Q13464 2/20 0.39
▸ CHEK2 O96017 1/20 0.39
▸ PRKACA P17612 1/20 0.39
▸ RPS6KA3 P51812 1/20 0.39
▸ PAK1 Q13153 1/20 0.39
▸ DYRK1A Q13627 1/20 0.39
▸ PRKD2 Q9BZL6 1/20 0.39
▸ EEF2K O00418 1/20 0.36
▸ MAP4K4 O95819 1/20 0.36
▸ CLK2 P49760 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ PRKX P51817 1/20 0.36
▸ NEK4 P51957 1/20 0.36
▸ PRKG2 Q13237 1/20 0.36
▸ PKN2 Q16513 1/20 0.36
▸ TAOK1 Q7L7X3 1/20 0.36
▸ AURKB Q96GD4 1/20 0.36
▸ PBK Q96KB5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25395149 1.00 ELANE (0.39) ELANEROCK2ROCK1CHEK2PRKACA
SCHEMBL24427867 0.84 ELANE (0.39) ELANEROCK2ROCK1CHEK2PRKACA
SCHEMBL3614409 0.83 KMT2A (0.40) ELANEROCK2ROCK1CHEK2PRKACA
SCHEMBL30376133 0.81 NPC1 (0.46) ELANEMAP2K4NPC1RAB9AEGFR
SCHEMBL17632197 0.81 NPC1 (0.46) ELANEMAP2K4NPC1RAB9AEGFR
SCHEMBL21986704 0.81 ELANE (0.37) ELANEROCK2ROCK1CHEK2PRKACA
SCHEMBL23043526 0.80 ELANE (0.40) ELANEROCK2ROCK1CHEK2PRKACA
SCHEMBL31106018 0.79 ROCK2 (0.41) ELANEROCK2ROCK1CHEK2PRKACA
SCHEMBL3695671 0.78 KMT2A (0.46) ELANEROCK2ROCK1CHEK2PRKACA
SCHEMBL12361357 0.78 ROCK2 (0.35) ELANEROCK2ROCK1CHEK2PRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118369323-A Heterocyclic compounds as SHP2 inhibitors, compositions comprising the same, and methods of use thereof 捷思英达控股有限公司 2024-07-19 — — CN disclosed
Send feedback